Legis Daily

Prescription Drug Price Reporting Act

USA116th CongressS-1664| Senate 
| Updated: 5/23/2019
Rick Scott

Rick Scott

Republican Senator

Florida

Cosponsors (3)
John Cornyn (Republican)Susan M. Collins (Republican)Cory Gardner (Republican)

Health, Education, Labor, and Pensions Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Prescription Drug Price Reporting Act This bill requires that all prescription drug manufacturers submit certain information for every drug marketed in the United States to the Department of Health and Human Services (HHS). Specifically, manufacturers must provide information about cost, pricing, and rebates. Manufacturers are also required to submit any price changes to a prescription drug at least 30 days in advance. HHS must make this information available through a public database that enables consumers to subscribe to price change notifications for different types of prescriptions drugs.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
May 23, 2019
Introduced in Senate
May 23, 2019
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Nov 22, 2019

Latest Companion Bill Action

HR 116-5239
Referred to the Subcommittee on Health.
  • May 23, 2019
    Introduced in Senate


  • May 23, 2019
    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.


  • November 22, 2019

    Latest Companion Bill Action

    HR 116-5239
    Referred to the Subcommittee on Health.

Health

Related Bills

  • HR 116-5239: Prescription Drug Price Reporting Act
Business recordsFederal preemptionGovernment information and archivesHealth care costs and insuranceInflation and pricesPrescription drugsRetail and wholesale tradesState and local government operations

Prescription Drug Price Reporting Act

USA116th CongressS-1664| Senate 
| Updated: 5/23/2019
Prescription Drug Price Reporting Act This bill requires that all prescription drug manufacturers submit certain information for every drug marketed in the United States to the Department of Health and Human Services (HHS). Specifically, manufacturers must provide information about cost, pricing, and rebates. Manufacturers are also required to submit any price changes to a prescription drug at least 30 days in advance. HHS must make this information available through a public database that enables consumers to subscribe to price change notifications for different types of prescriptions drugs.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
May 23, 2019
Introduced in Senate
May 23, 2019
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Nov 22, 2019

Latest Companion Bill Action

HR 116-5239
Referred to the Subcommittee on Health.
  • May 23, 2019
    Introduced in Senate


  • May 23, 2019
    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.


  • November 22, 2019

    Latest Companion Bill Action

    HR 116-5239
    Referred to the Subcommittee on Health.
Rick Scott

Rick Scott

Republican Senator

Florida

Cosponsors (3)
John Cornyn (Republican)Susan M. Collins (Republican)Cory Gardner (Republican)

Health, Education, Labor, and Pensions Committee

Health

Related Bills

  • HR 116-5239: Prescription Drug Price Reporting Act
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Business recordsFederal preemptionGovernment information and archivesHealth care costs and insuranceInflation and pricesPrescription drugsRetail and wholesale tradesState and local government operations